“Combating the pandemic will require more than one vaccine product in order to ensure sufficient supplies.” CureVac COVID19 Vaccine Germany Coronavirus Pandemic Cure
The Paul Ehrlich Institute , the German body responsible for assessing clinical trials and approving vaccines, called the approval “an important milestone”.
CureVac’s milestone comes just two days after the German government said it was spending 300 million euros to take a 23-percent stake in the firm, in an apparent attempt to stop it from ending up in foreign hands. Both the firm and US officials denied the claim, but the reports sparked outrage in Berlin and prompted Economy Minister Peter Altmaier to declare that “Germany is not for sale”.CureVac is the second German company to move to the trial phase after the Paul Ehrlich Institute in April authorised clinical tests for a vaccine against COVID-19 being developed by Germany’s Biontech with US giant Pfizer.
CureVac’s trial will involve 168 healthy volunteers, of whom 144 will be injected with the experimental vaccine starting this month.
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Another 400 COVID-19 cases confirmed at German slaughterhouseWe are a quality, national, newspaper with credible and dependable information.
Read more »
Germany's biotech firm gets approval for COVID-19 vaccine human trial - HealthwiseGerman biotech firm CureVac has won permission to start human trials of a promising coronavirus vaccine, regulators announced on Wednesday. The Paul Ehrlich Institute, the German body responsible for assessing clinical trials and approving vaccines, called the approval “an important milestone”. In a statement, it said it had given CureVac the green light …
Read more »
COVID-19: Germany kits enforcement agents with PPEs
Read more »
Bayelsa confirms 54 new COVID-19 cases - The Nation NigeriaBayelsa has recorded 54 new cases of COVID-19, the Deputy Chairman of the state COVID-19 Task Force, Dr Inodu Akpoku, has disclosed....
Read more »
Breakthrough Beckons as Trial Shows UK Drug, Dexamethasone, Reduces COVID-19 Death Rate - THISDAYLIVEBy Martins Ifijeh There appears to be a major breakthrough in the fight against COVID-19 pandemic as dexamethasone, a cheap and widely available low-dose steroid drug, has shown efficacy for preventing critically ill COVID-19 patients from dying, according to a BBC report. The drug is part of the world’s biggest existing medicine under clinical trial …
Read more »
UK okays dexamethasone for COVID-19 treatmentThe steroid dexamethasone was shown Tuesday to be the first drug to significantly reduce the risk of death among severe COVID-19 cases, in trial results hailed as a
Read more »